Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Drilling at Pt. Leamington unveils a copper-rich extension, targeting near-surface high-grade zones (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Abeona Therapeutics Inc ABEO

Healthcare Biotechnology
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ABEO)

Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference

GlobeNewswire 2 days ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 9, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 31, 2025

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

GlobeNewswire December 15, 2025

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas

GlobeNewswire December 11, 2025

Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy

GlobeNewswire December 8, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 1, 2025

Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire November 12, 2025

Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation

GlobeNewswire November 7, 2025
View More News ››

Opinion & Analysis (NDAQ:ABEO)

Risk Versus Reward: The Value of Cell Therapy for Patients and Investors

Streetwise Reports April 25, 2018

2017 Small-Cap Biotech Watchlist update: up 21% at the end of Q2/17

The Life Sciences Report July 14, 2017

2017 Small-Cap biotech watchlist update: holding steady in a volatile market

The Life Sciences Report April 21, 2017

2017 Small-Cap Biotech Watchlist: takeaways for investors

The Life Sciences Report January 19, 2017

19 companies selected for the 2017 Small-Cap Biotech Watchlist

The Life Sciences Report January 5, 2017
View More Opinion ››

Bullboard Posts (NDAQ:ABEO)

Buy buddy buy because it's taking off this morning.

And furthermore,you guys should be getting on-board with this stock already
coolfooldumbguy - April 29, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO): Navigating the Chall

http://beyondspx.com/2024/08/01/abeona-therapeutics-inc-nasdaqabeo-navigating-the-challenges-and-opportunities-in-cell-and-gene-therapy/
MikeTester - August 1, 2024

ABEO

UP UP AND AWAY!!!!!!
WakeUPP - December 23, 2020

doing really well

glta shareholders.
coolfooldumbguy - February 19, 2020

still holding this stock

it's doing well for shareholders so far,so glta.
coolfooldumbguy - February 18, 2020

it's a buy today for me

at these low prices,it's making a comeback,so glta shareholders.
coolfooldumbguy - February 11, 2020
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. operates as a cybersecurity and internet privacy provider of Swiss hosted solutions for secure ...
View More »

Podcasts